74 participants
A Study of TS-1 Plus Irinotecan and Cisplatin (IP) for Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2010-10-25
- Start Date:
- 2008-10-31
- Completion:
- 2011-12-31
Conditions
- Advanced Non-Small Cell Lung Cancer
Interventions
- DRUG
No Results Yet